A replicated patient-specific component of tumour telomere length across two pan-cancer cohorts
Bulk telomere length measured from tumour sequencing is routinely interpreted as a property of the cancer cells. However, a tumour specimen is a mixture, and the patient who supplies it has a telomere length of their own. Here I re-analyse published pan-cancer telomere estimates and ask how much of a tumour's telomere length is patient-specific. A calibration step comes first. Whole-genome and…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
